AstraZeneca shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of AstraZeneca shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $131M | 1.4M | 91.93 |
| 2025-09-30 | $3.2M | 42k | 76.72 |
| 2025-06-30 | $1.4M | 21k | 69.88 |
| 2025-03-31 | $2.3M | 31k | 73.50 |
| 2024-12-31 | $1.7M | 25k | 65.52 |
| 2024-09-30 | $1.4M | 18k | 77.91 |
| 2024-06-30 | $997k | 13k | 77.99 |
| 2024-03-31 | $675k | 10k | 67.75 |
| 2023-12-31 | $686k | 10k | 67.35 |
| 2023-09-30 | $773k | 11k | 67.72 |
| 2023-06-30 | $846k | 12k | 71.57 |
| 2023-03-31 | $782k | 11k | 69.41 |
| 2022-12-31 | $5.5M | 82k | 67.80 |
| 2022-09-30 | $14M | 246k | 54.84 |
| 2022-06-30 | $56M | 851k | 66.07 |
| 2022-03-31 | $438k | 6.6k | 66.31 |
| 2021-12-31 | $1.7M | 30k | 58.25 |
| 2020-06-30 | $5.8M | 110k | 52.89 |
| 2019-06-30 | $4.7M | 113k | 41.28 |
| 2019-03-31 | $1.5M | 37k | 40.44 |
| 2018-12-31 | $2.9M | 77k | 37.98 |
| 2017-06-30 | $4.3M | 126k | 34.09 |
| 2016-09-30 | $1.4M | 43k | 32.85 |
| 2016-06-30 | $1.6M | 53k | 30.18 |
| 2016-03-31 | $1.5M | 53k | 28.15 |
| 2015-12-31 | $1.8M | 53k | 33.96 |
| 2015-09-30 | $1.9M | 58k | 31.82 |
| 2015-06-30 | $1.9M | 29k | 63.70 |
| 2015-03-31 | $2.6M | 30k | 86.67 |
| 2014-12-31 | $2.1M | 30k | 70.37 |
| 2014-09-30 | $2.1M | 30k | 71.45 |
| 2014-06-30 | $2.4M | 31k | 79.16 |
| 2014-03-31 | $3.3M | 47k | 71.61 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management